Brief: Pasithea Therapeutics Launches In-Home Intravenous Ketamine Therapy In Major U.S. Cities
17/11/2021 13:17
Nov 17 (Reuters) - Pasithea Therapeutics Corp KTTA.O :
* PASITHEA THERAPEUTICS LAUNCHES IN-HOME INTRAVENOUS
KETAMINE
THERAPY IN MAJOR U.S. CITIES, EXPANDING ITS INTERNATIONAL
FOOTPRINT
* PASITHEA THERAPEUTICS CORP - FIRST MOBILE CLINICS LAUNCH
IN NEW
YORK CITY, LOS ANGELES, SAN DIEGO, AND SAN FRANCISCO
* PASITHEA THERAPEUTICS CORP - EXPANSION TO ADDITIONAL U.S.
CITIES
IN COMING MONTH
Source text for Eikon: ID:nGNX3MvzvD
Further company coverage: KTTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pasithea Therapeutics
See all newsPasithea Therapeutics Corp reports results for the quarter ended June 30 - Earnings Summary
Pasithea Therapeutics Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data
Brief: Pasithea Therapeutics Announces Closing Of $60 Million Public Offering Of Common Stock
Pasithea Therapeutics jumps after $60 million public offering announcement